The safety evidence from TRAVERSE refers to men with confirmed low testosterone levels — below 300 nanograms per decilitre of ...
Testosterone replacement therapy does not improve glycemic control in men with hypogonadism. Although low testosterone levels are associated with increased risks for prediabetes and type 2 diabetes in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results